Cargando…
Clinical Aspects of Genetic and Non-Genetic Cardiovascular Risk Factors in Familial Hypercholesterolemia
Familial hypercholesterolemia (FH) is the most common monogenic metabolic disorder characterized by considerably elevated low-density lipoprotein cholesterol (LDL-C) levels leading to enhanced atherogenesis, early cardiovascular disease (CVD), and premature death. However, the wide phenotypic hetero...
Autores principales: | Berta, Eszter, Zsíros, Noémi, Bodor, Miklós, Balogh, István, Lőrincz, Hajnalka, Paragh, György, Harangi, Mariann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321861/ https://www.ncbi.nlm.nih.gov/pubmed/35885941 http://dx.doi.org/10.3390/genes13071158 |
Ejemplares similares
-
Impact of selective LDL apheresis on serum chemerin levels in patients with hypercholesterolemia
por: Varga, Viktória E., et al.
Publicado: (2016) -
Sphingosine 1-Phosphate and Apolipoprotein M Levels and Their Correlations with Inflammatory Biomarkers in Patients with Untreated Familial Hypercholesterolemia
por: Juhász, Lilla, et al.
Publicado: (2022) -
Determination of Serum Progranulin in Patients with Untreated Familial Hypercholesterolemia
por: Nádró, Bíborka, et al.
Publicado: (2022) -
Decreased Serum Stromal Cell-Derived Factor-1 in Patients with Familial Hypercholesterolemia and Its Strong Correlation with Lipoprotein Subfractions
por: Juhász, Lilla, et al.
Publicado: (2023) -
Advanced glycation end products and their soluble receptor (sRAGE) in patients with Hashimoto’s thyroiditis on levothyroxine substitution
por: Csiha, Sára, et al.
Publicado: (2023)